The combination of Ypsomed’s connected devices and Philips’ (NYSE:PHG) cloud-based digital platform will allow Ypsomed’s pharmaceutical customers to deliver value-added services aimed at improving patient outcomes, the companies said in a joint statement. They intend to sign the definitive agreements in the fourth quarter of 2018.
Ypsomed describes its SmartServices as a new turnkey digital solution for medication adherence monitoring and smart device management. Philips’ HealthSuite digital platform provides tools and services focused on ease-of-integration, digital lifecycle management, and end-to-end security, according to that company.
Ypsomed makes injections pens, autoinjectors and infusion systems to administer liquid drugs. The new digital services aim to address a wide range of device-oriented challenges and support self-medication services for patients across chronic disease states, such as diabetes, multiple sclerosis, and rheumatoid arthritis.
“Our partnership with Philips aims at embedding smart devices in a digital health ecosystem that simplifies access to therapy-relevant medication adherence data,” said Ulrike Bauer, senior vice president of Ypsomed Delivery Systems, in the statement. “This will allow our pharmaceutical customers to focus on building therapy-specific digital solutions for patients, caregivers, and physicians.”
Integrating Ypsomed’s smart devices and data into HealthSuite will enable pharma companies to achieve shorter time-to-market, scale-up solutions in a secure HIPAA-compliant way, and integrate data from Ypsomed devices with other data sources to support other value-added use cases, said Philips’ HealthSuite business leaderDale Wiggins.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.